Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.2420
+0.0020 (0.83%)
At close: Sep 17, 2025, 4:00 PM EDT
0.2413
-0.0007 (-0.29%)
After-hours: Sep 17, 2025, 7:39 PM EDT
Intensity Therapeutics Market Cap
Intensity Therapeutics has a market cap or net worth of $11.87 million as of September 17, 2025. Its market cap has decreased by -80.18% in one year.
Market Cap
11.87M
Enterprise Value
9.90M
1-Year Change
-80.18%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since the IPO on June 30, 2023, Intensity Therapeutics's market cap has decreased from $66.01M to $11.87M, a decrease of -82.02%. That is a compound annual growth rate of -53.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 11.87M | -55.34% |
| Dec 31, 2024 | 26.58M | -77.37% |
| Dec 29, 2023 | 117.49M | 77.98% |
| Jun 30, 2023 | 66.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |